Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmacological activity/properties

The therapeutically active dmg can be extracted from plant or animal tissue, or be a product of fermentation (qv), as in the case of antibiotics. Frequentiy, it is synthesized and designed to correlate stmcture with therapeutic activity. Pharmacologic activity is first tested on laboratory animals. When the results ate encouraging, physical and chemical properties are determined in the so-called preformulation stage, and analytical procedures are developed for quahty control (see Qualityassurance/qualitycontrol). [Pg.225]

Increasing attention has been paid to the generation of quantitative stmcture—activity relationships in which the effects of molecular substitution on pharmacologic activity can be interpreted in terms of the physicochemical properties of the substituents. These approaches are based on the extrathermodynamic analysis of substituent effects (36) ... [Pg.273]

Most of the pharmacologically active indazole derivatives are useful as antiinflammatory drugs, e.g. bendazac or [(1-benzyl-l J/-indazol-3-yl)oxy]acetic acid (LDso in mice and rats of 355 and 388mgkg i.p., respectively) and benzydamine or l-benzyl-3-[3-(dimethyl-amino)propoxy]-l//-indazole (LDso in mice and rats of 110 and lOOmgkg" i.p., respectively). The last cited compound also has analgesic and antipyretic properties (B-76MI40404). [Pg.293]

Pteridine, 2,4,7-triamino-6-phenyl-pharmacological activity, 3, 325 Pteridine, 2,4,6-trichloro-properties, 3, 267 Pteridine, 2,4,7-trichloro-properties, 3, 267 reaction, 3, 291 Pteridine, 4,6,7-trichloro-reaction, 3, 291 Pteridine, 4-trifluoromethyl-structure, 3, 266 Pteridine, 2,6,7-trimethyl-structure, 3, 266 Pteridine, 4,6,7-trimethyl-NMR, 3, 266... [Pg.753]

Pharmacological activity spectrum and toxicological properties of benzimidazole derivatives 99KFZ(5)6. [Pg.235]

Enantiomers have identical chemical properties, except when they react with other chiral compounds. Because many biochemical substances are chiral, one consequence of this difference in reactivity is that enantiomers may have different odors and pharmacological activities. The molecule has to fit into a cavity, or slot, of a certain shape, either in an odor receptor in the nose or in an enzyme. Only one member of the enantiomeric pair may be able to fit. [Pg.855]

In recent years it has been realized that molecular modeling studies of the alkaloidal molecules having different pharmacological activities are highly important in order to explain their mechanisms, at least partially in some cases. This chapter presents and critically reviews some examples of molecular modeling studies of alkaloids, based on their different biological properties or sometimes performed in parallel to explain their biochemical effects. [Pg.76]

Abstract Protoberberine alkaloids and related compounds represent an important class of molecules and have attracted recent attention for their various pharmacological activities. This chapter deals with the physicochemical properties of several isoquinoline alkaloids (berberine, palmatine and coralyne) and many of their derivatives under various environmental conditions. The interaction of these compounds with polymorphic DNA structures (B-form, Z-form, H -form, protonated form, triple helical form and quadruplex form) and polymorphic RNA structures (A-form, protonated form, triple helical form and quadruplex form) reported by several research groups, employing various analytical techniques such as spectrophotometry, spectrofluorimetry, circular dichro-ism, NMR spectroscopy, viscometry as well as molecular modelling and thermodynamic analysis to elucidate their mode and mechanism of action for structure-activity relationships, are also presented. [Pg.156]

Therapeutic properties of herbs have been known for many years. They were once used in folk medicine, but recently herb therapy has become popular again. It is known that widely nsed herbal infnsions or tinctures contain a wide spectrum of compounds ranguig from very important pharmacologically active ones to those with small or sometimes undesirable activity. [Pg.252]

In the discovery phase, a reaction route is developed to allow synthesis of a maximum number of analogues for pharmacological testing. Since the focus is on synthetic flexibility, issues of scale are not central. Once a lead compound exhibits a useful pharmacological activity and is identified as a candidate for further development, larger scale synthesis is required to evaluate stability, bioavailability, toxicity, physicochemical properties, and other compound properties. The Chemical Development Department is usually involved in the preparation of supplies for these activities. [Pg.173]

Yohimbine (36) is a well-known and reasonably available alkaloid from Corynanthe yohimbe, inter alia. For this reason, and partly because of its intrinsic pharmacological activity (including reputed aphrodisiac activity), chemists have frequently studied its properties. Oppenauer oxidation is usually attended by saponification and decarboxylation in this series, and yohimbone (37) is the product. Wolf-Kischner reduction to yohimbane (38), followed by sodium hydride mediated alkylation, leads to the analgesic agent, mimbane (39). °... [Pg.347]

Many polymers have been studied for their usefulness in producing pharmacologically active complexes with proteins or drugs. Synthetic and natural polymers such as polysaccharides, poly(L-lysine) and other poly(amino acids), poly(vinyl alcohols), polyvinylpyrrolidinones, poly(acrylic acid) derivatives, various polyurethanes, and polyphosphazenes have been coupled to with a diversity of substances to explore their properties (Duncan and Kopecek, 1984 Braatz et al., 1993). Copolymer preparations of two monomers also have been tried (Nathan et al., 1993). [Pg.936]


See other pages where Pharmacological activity/properties is mentioned: [Pg.77]    [Pg.249]    [Pg.17]    [Pg.29]    [Pg.126]    [Pg.587]    [Pg.156]    [Pg.286]    [Pg.254]    [Pg.9]    [Pg.16]    [Pg.700]    [Pg.2]    [Pg.267]    [Pg.47]    [Pg.76]    [Pg.3]    [Pg.103]    [Pg.146]    [Pg.713]    [Pg.735]    [Pg.533]    [Pg.754]    [Pg.265]    [Pg.339]    [Pg.96]    [Pg.101]    [Pg.4]    [Pg.7]    [Pg.477]    [Pg.531]    [Pg.459]    [Pg.936]    [Pg.5]   


SEARCH



Activated properties

Pharmacologic activity

Pharmacological activity/properties heterocyclic chemistry

Pharmacologically active

Pharmacology activity

Platelet-activating factor pharmacological properties

Quantitative structure-property relationship pharmacological activity

© 2024 chempedia.info